Regentis Biomaterials (NYSEMKT: RGNT) is owned by 5.43% institutional shareholders, 0.00% Regentis Biomaterials insiders, and 94.57% retail investors. Rosalind Advisors Inc is the largest individual Regentis Biomaterials shareholder, owning 251,510.00 shares representing 4.86% of the company. Rosalind Advisors Inc's Regentis Biomaterials shares are currently valued at $845.07k.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.